1. Type 2 diabetes: Getting up to speed;Vivian;Am Druggist,1999
2. Effects of the hypoglycaemic drugs repaglinide and glibenclamide on ATP-sensitive potassium-channels and cytosolic calcium levels in beta TC3 cells and rat pancreatic beta cells;Gromada;Diabetologia,1995
3. Characterization of the binding-sites for the novel anti-hyperglycemic drug, repaglinide;Fuhlendorff;Diabetes,1995
4. Molecular identification of a specific binding-site (36 kda) for repaglinide;Fuhlendorff;Diabetes,1998
5. A new oral hypoglycemic agent, repaglinide minimizes risk of hypoglycemia in well-controlled NIDDM patients;Tronier;Diabetologia,1995